ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Tonic convulsion,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
4,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
5,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
5,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
7,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
9,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
9,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
10,1,Anaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
10,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,1,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
11,2,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
11,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
11,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
12,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
12,2,Headache,Headaches NEC,Headaches,Nerv,N
12,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
12,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
13,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
14,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
15,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
16,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
16,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
17,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
17,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
18,1,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
19,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
19,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
19,3,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
19,4,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
19,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
21,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
22,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
23,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
23,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
24,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
24,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
25,1,Headache,Headaches NEC,Headaches,Nerv,N
25,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
26,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
27,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
27,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
28,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
28,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
29,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
29,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
30,2,Tachyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
31,1,Drug withdrawal convulsions,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
32,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
33,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
33,2,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
34,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
35,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
35,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
36,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
37,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
38,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
39,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
40,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
41,1,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
42,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
42,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
42,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
43,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
43,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
44,1,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
44,2,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
44,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
45,1,Headache,Headaches NEC,Headaches,Nerv,N
46,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
47,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
47,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
47,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
47,4,Psychogenic blindness,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
47,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
47,6,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
47,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
48,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
49,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
49,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
50,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
56,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
56,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Disturbance in sexual arousal,Sexual arousal disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
57,2,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
57,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
57,4,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
58,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
58,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
59,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
60,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
61,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
61,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
62,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
63,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
63,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
64,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
64,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
65,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
66,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
66,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
66,3,Myoclonic epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
67,1,Neonatal seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
68,1,Neonatal seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
69,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
69,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
69,3,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
70,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
71,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
72,1,Athetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
72,2,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
73,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
74,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
74,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
74,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
74,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
74,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
75,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
76,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
77,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
77,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
78,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
78,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
79,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
79,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
79,3,Sputum increased,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
80,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
80,2,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
81,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
82,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
83,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
84,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
85,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
86,1,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
86,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
87,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
87,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
87,3,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
88,1,Headache,Headaches NEC,Headaches,Nerv,N
88,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
89,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
89,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
90,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
90,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
90,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
91,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
91,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
91,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
91,4,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
91,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
91,6,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
92,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
92,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
93,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
94,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
95,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
96,1,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
97,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
97,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
97,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
98,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
99,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
99,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
100,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
101,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
101,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
102,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
103,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
104,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
104,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
105,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
105,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
106,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
107,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
108,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
108,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
109,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
110,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
110,2,Headache,Headaches NEC,Headaches,Nerv,N
111,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
111,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
112,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
112,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
113,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
113,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
114,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
115,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
116,1,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
116,2,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
117,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
118,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
118,2,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
119,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
119,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
119,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
119,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
120,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
121,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
122,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
123,1,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
124,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
125,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
126,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
126,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
126,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
127,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
128,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
129,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
129,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
129,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
129,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
130,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
131,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
132,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
133,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
134,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
134,2,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
135,1,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
136,1,Headache,Headaches NEC,Headaches,Nerv,N
137,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
137,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
137,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
137,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
137,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
138,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
139,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
140,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
140,2,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
141,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
142,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
142,2,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
143,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
144,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
145,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
146,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
147,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
148,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
149,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
149,2,Therapeutic response increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
150,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
151,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
152,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
152,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
153,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
154,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
155,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
156,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
156,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
158,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
159,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
160,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
161,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
162,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
162,2,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
162,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
162,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
162,5,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
162,6,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
163,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
164,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
165,1,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
166,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
167,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
167,2,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
168,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
168,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
169,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
170,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
171,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
171,2,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
172,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
173,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
174,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
174,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
175,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
175,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
176,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
176,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
177,1,Headache,Headaches NEC,Headaches,Nerv,N
177,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
177,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
178,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
178,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
178,3,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
178,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
179,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
180,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
181,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
181,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
182,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
183,1,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
183,2,Postictal paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
184,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
184,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
185,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
185,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
186,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
187,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
187,2,Headache,Headaches NEC,Headaches,Nerv,N
187,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
187,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
187,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
188,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
188,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
189,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
190,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
190,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
191,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
191,2,Peripheral circulatory failure,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
191,3,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
191,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
192,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
192,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
193,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
193,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
194,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
194,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
195,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
196,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
197,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
197,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
198,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
198,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
198,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
198,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
198,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
199,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
200,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
201,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
201,3,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
202,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
203,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
203,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
204,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
205,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
206,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
206,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
207,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
208,1,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
209,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
209,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
209,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
209,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
209,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
209,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
209,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
210,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
211,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
212,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
213,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
214,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
214,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
214,3,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
214,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
215,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
215,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
216,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
216,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
216,3,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
217,1,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
218,1,Deafness transitory,Hearing losses,Hearing disorders,Ear,N
219,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
220,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
221,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
222,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
222,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
222,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
222,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
223,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
223,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
223,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
224,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
225,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
226,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
227,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
227,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
228,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
228,2,Carotid artery occlusion,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
228,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
229,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
229,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
230,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
230,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
230,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
230,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
231,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
231,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
231,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
232,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
232,2,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
233,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
233,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
234,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
234,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
234,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
235,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
235,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
236,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
236,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
236,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
237,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
238,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
239,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
239,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
240,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
240,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
240,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
240,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
240,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
241,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
241,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
241,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
241,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
241,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
242,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
243,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
243,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
244,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
245,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
246,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
247,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
247,2,Headache,Headaches NEC,Headaches,Nerv,N
247,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
247,4,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
248,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
248,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
248,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
249,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
249,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
250,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
251,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
252,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
252,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
252,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
253,1,Headache,Headaches NEC,Headaches,Nerv,N
254,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
255,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
256,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
257,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
258,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
258,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
258,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
258,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
259,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
260,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
261,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
261,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
262,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
262,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
263,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
264,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
264,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
264,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
265,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
266,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
267,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
268,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
269,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
269,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
269,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
269,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
269,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
270,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
270,2,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
270,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
270,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
271,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
271,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
272,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
273,1,Headache,Headaches NEC,Headaches,Nerv,N
273,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
274,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
275,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
276,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
277,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
278,1,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
279,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
280,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
280,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
280,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
281,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
281,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
281,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
282,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
283,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
283,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
283,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
283,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
284,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
284,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
285,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
285,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
286,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
287,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
288,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
288,2,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
289,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
290,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
290,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
290,3,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
291,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
292,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
293,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
294,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
294,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
295,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
295,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
296,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
296,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
297,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
297,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
297,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
297,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
298,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
298,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
299,1,Asphyxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
299,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
300,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
300,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
300,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
300,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
300,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
300,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
300,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
301,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
302,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
302,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
303,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
304,1,Headache,Headaches NEC,Headaches,Nerv,N
304,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
305,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
305,2,Headache,Headaches NEC,Headaches,Nerv,N
305,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
305,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
305,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
305,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
306,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
306,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
307,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
308,1,Cardio-respiratory arrest neonatal,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
309,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
309,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
310,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
311,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
312,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
312,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
312,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
312,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
313,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
313,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
313,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
313,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
314,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
315,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
316,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
317,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
317,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
318,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
318,2,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
318,3,Myoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
319,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
319,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
320,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
320,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
320,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
321,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
322,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
323,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
324,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
324,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
325,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
326,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
326,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
326,3,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
327,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
327,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
328,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
329,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
330,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
330,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
330,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
330,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
330,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
331,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
332,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
332,2,Tonic clonic movements,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
333,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
333,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
333,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
333,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
334,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
335,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
335,2,Migraine with aura,Migraine headaches,Headaches,Nerv,N
336,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
337,1,Brain hypoxia,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
337,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
338,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
338,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
339,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
340,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
340,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
341,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
342,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
342,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
342,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
343,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
343,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
344,1,Headache,Headaches NEC,Headaches,Nerv,N
345,1,Central sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
346,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
347,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
348,1,Inner ear disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
349,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
349,2,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
350,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
351,1,Central sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
352,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
353,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
353,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
353,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
353,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
354,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
354,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
354,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
354,4,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
354,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
355,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
355,2,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
356,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
356,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
357,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
357,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
357,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
357,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
357,5,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
357,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
358,1,Retinitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
359,1,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
360,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
361,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
361,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
362,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
362,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
363,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
363,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
363,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
363,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
364,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
364,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
364,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
364,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
364,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
364,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
365,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
365,2,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
366,1,Lip erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
366,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
366,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
366,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
367,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
368,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
369,1,Coma,Coma states,Neurological disorders NEC,Nerv,Y
369,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
370,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
370,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
370,3,Hyperthermia malignant,Body temperature altered,Body temperature conditions,Genrl,Y
370,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
371,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
371,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
372,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
373,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
373,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
374,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
375,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
375,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
375,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
375,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
376,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
376,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
377,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
377,2,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
378,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
378,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
379,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
380,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
380,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
381,1,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
382,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
382,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
382,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
382,4,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
382,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
383,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
383,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
384,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
385,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
385,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
385,3,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
385,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
386,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
386,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
387,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
387,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
387,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
387,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
387,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
387,6,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
387,7,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
388,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
389,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
390,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
391,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
392,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
392,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
392,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
393,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
393,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
394,1,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,Y
394,2,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
395,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
396,1,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
396,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
396,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
396,4,Oxygen saturation abnormal,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
396,5,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
396,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
397,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
397,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
397,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
398,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
398,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
398,3,Opisthotonus,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
398,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
399,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
399,2,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
399,3,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
400,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
401,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
402,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
403,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
404,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
405,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
406,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
406,2,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
406,3,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
406,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
406,5,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
406,6,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
406,7,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
406,8,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
406,9,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
406,10,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
406,11,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
406,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
406,13,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
407,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
407,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
408,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
408,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
409,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
410,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
410,2,Drug abuser,Drug and chemical abuse,Lifestyle issues,SocCi,N
410,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
410,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
411,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
411,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
412,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
412,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
413,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
414,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
414,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
414,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
415,1,Gastrointestinal neoplasm,Gastrointestinal neoplasms malignancy unspecified NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
416,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
416,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
417,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
418,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
418,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
418,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
418,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
419,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
419,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
420,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
420,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
421,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
421,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
421,3,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
422,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
423,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
424,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
424,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
424,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
425,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
425,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
425,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
425,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
426,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
426,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
426,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
426,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
426,5,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
426,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
427,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
427,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
427,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
427,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
428,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
428,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
428,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
429,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
429,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
429,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
429,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
430,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
430,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
430,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
431,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
431,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
432,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
432,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
433,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
434,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
435,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
435,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
436,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
437,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
438,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
438,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
438,3,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
438,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
439,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
440,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
441,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
441,2,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
441,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
441,4,Headache,Headaches NEC,Headaches,Nerv,N
441,5,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
441,6,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
441,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
441,8,Migraine with aura,Migraine headaches,Headaches,Nerv,N
441,9,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
442,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
442,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
442,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
443,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
444,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
445,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
446,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
447,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
448,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
449,1,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
449,2,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
449,3,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
449,4,Headache,Headaches NEC,Headaches,Nerv,N
449,5,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
450,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
451,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
451,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
451,3,Product tampering,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
451,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
452,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
452,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
452,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
453,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
454,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
454,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
455,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
456,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
457,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
457,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
457,3,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
458,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
459,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
460,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
460,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
460,3,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
460,4,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
460,5,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
460,6,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
460,7,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
460,8,Congestive hepatopathy,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
460,9,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
460,10,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
460,11,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
460,12,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
460,13,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
460,14,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
460,15,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
460,16,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
460,17,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
460,18,Hepatic ischaemia,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
460,19,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
460,20,Hepatorenal syndrome,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
460,21,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
460,22,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
460,23,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
460,24,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
460,25,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
460,26,Muscle relaxant therapy,Muscle therapeutic procedures,Soft tissue therapeutic procedures,Surg,N
460,27,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
460,28,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
460,29,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
460,30,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
460,31,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
461,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
462,1,Amnestic disorder,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
463,1,Anterograde amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
463,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
464,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
465,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
466,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
467,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
468,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
468,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
469,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
470,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
471,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
471,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
471,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
472,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
473,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
473,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
473,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
474,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
475,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
475,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
476,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
477,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
477,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
478,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
479,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
480,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
480,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
481,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
481,2,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
481,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
481,4,Sinus arrhythmia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
482,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
482,2,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
483,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
483,2,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
484,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
484,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
484,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
485,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
485,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
485,3,Hypoventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
485,4,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
485,5,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
485,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
486,1,Procedural hypotension,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
487,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
488,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
488,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
488,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
488,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
488,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
489,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
489,2,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
489,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
489,4,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
489,5,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
489,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
489,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
489,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
489,9,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
490,1,Contraindication to medical treatment,Social issues NEC,Lifestyle issues,SocCi,N
490,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
490,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
490,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
490,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
491,1,Lissencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,Y
491,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
491,3,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
491,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
492,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
492,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
492,3,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
493,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
493,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
494,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
494,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
494,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
494,4,Cardiac output decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
495,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
495,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
495,3,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
495,4,Vein discolouration,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
496,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
496,2,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
497,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
497,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
497,3,Endotracheal intubation,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
497,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
497,5,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
497,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
497,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
497,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
498,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
498,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
498,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
499,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
499,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
499,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
500,1,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
500,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
501,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
502,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
503,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
504,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
505,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
506,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
506,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
506,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
506,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
506,5,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
506,6,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
506,7,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
506,8,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
506,9,Cerebral ventricle dilatation,Structural brain disorders NEC,Structural brain disorders,Nerv,N
506,10,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
506,11,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
506,12,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
506,13,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
506,14,Distractibility,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
506,15,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
506,16,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
506,17,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
506,18,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
506,19,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
506,20,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
506,21,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
506,22,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
506,23,Focal dyscognitive seizures,Partial complex seizures,Seizures (incl subtypes),Nerv,N
506,24,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
506,25,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
506,26,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
506,27,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
506,28,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
506,29,Hyperexplexia,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
506,30,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
506,31,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
506,32,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
506,33,Microcephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
506,34,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
506,35,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
506,36,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
506,37,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
506,38,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
506,39,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
506,40,Suspiciousness,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
506,41,Tonic clonic movements,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
506,42,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
506,43,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
506,44,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
507,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
508,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
509,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
509,2,Unwanted awareness during anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
510,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
510,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
510,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
510,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
510,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
510,6,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
510,7,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
510,8,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
511,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
511,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
511,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
512,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
512,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
512,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
513,1,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
513,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
514,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
514,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
515,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
516,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
517,1,Brief resolved unexplained event,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
517,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
517,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
517,4,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
518,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
518,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
519,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
519,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
519,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
519,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
519,5,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
520,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
521,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
521,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
521,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
522,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
523,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
523,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
523,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
524,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
524,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
525,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
526,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
526,2,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
526,3,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
526,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
527,1,Brain death,Death and sudden death,Fatal outcomes,Genrl,Y
527,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
527,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
527,4,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
528,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
529,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
529,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
529,3,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
529,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
529,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
529,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
529,7,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
529,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
530,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
530,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
530,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
531,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
531,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
531,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
532,1,Retrograde amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
533,1,Seizure like phenomena,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
533,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
534,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
535,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
536,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
537,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
537,2,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
538,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
539,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
540,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
541,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
542,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
543,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
544,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
544,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
544,3,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
544,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
544,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
544,6,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
544,7,Oxygen saturation abnormal,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
544,8,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
545,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
546,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
546,2,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
547,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
547,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
547,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
547,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
547,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
547,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
547,7,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
547,8,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
547,9,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
547,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
547,11,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
547,12,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
547,13,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
547,14,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
547,15,Product deposit,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
547,16,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
547,17,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
547,18,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
548,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
548,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
548,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
548,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
548,5,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
548,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
549,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
550,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
550,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
551,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
551,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
552,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
553,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
553,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
554,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
555,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
556,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
557,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
558,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
559,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
559,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
560,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
561,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
561,2,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
562,1,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
562,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
563,1,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
564,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
565,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
566,1,Foetal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
566,2,Neonatal respiratory depression,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
567,1,Foetal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
567,2,Neonatal respiratory depression,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
568,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
569,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
569,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
569,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
569,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
570,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
570,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
570,3,Migraine,Migraine headaches,Headaches,Nerv,N
570,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
570,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
571,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
572,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
573,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
573,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
573,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
574,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
575,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
575,2,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
575,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
575,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
575,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
576,1,Lip and/or oral cavity cancer,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
576,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
577,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
578,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
579,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
579,2,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
579,3,Irregular breathing,Breathing abnormalities,Respiratory disorders NEC,Resp,N
579,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
579,5,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
579,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
580,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
581,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
581,2,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
581,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
581,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
581,5,Saliva discolouration,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
581,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
581,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
582,1,Failure to thrive,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
582,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
582,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
583,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
583,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
583,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
583,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
584,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
585,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
585,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
585,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
585,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
585,5,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
585,6,Dissociative amnesia,Dissociative states,Dissociative disorders,Psych,N
585,7,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
585,8,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
585,9,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
585,10,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
585,11,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
585,12,Headache,Headaches NEC,Headaches,Nerv,N
585,13,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
585,14,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
585,15,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
585,16,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
585,17,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
585,18,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
585,19,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
585,20,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
585,21,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
585,22,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
585,23,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
585,24,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
585,25,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
585,26,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
585,27,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
585,28,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
585,29,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
585,30,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
586,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
587,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
587,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
588,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
589,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
590,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
590,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
590,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
590,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
590,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
590,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
591,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
591,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
592,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
592,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
592,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
592,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
593,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
593,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
594,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
594,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
594,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,Y
595,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
595,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
596,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
596,2,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
596,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
597,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
598,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
598,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
598,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
598,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
598,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
598,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
598,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
598,8,Inflammation,Inflammations,General system disorders NEC,Genrl,N
598,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
598,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
598,11,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
598,12,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
598,13,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
598,14,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
598,15,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
598,16,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
598,17,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
598,18,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
598,19,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
598,20,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
598,21,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
599,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
600,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
600,2,Dissociative disorder,Dissociative states,Dissociative disorders,Psych,N
600,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
600,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
600,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
600,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
601,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
601,2,Physical assault,Criminal activity,Legal issues,SocCi,N
602,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
602,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
603,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
603,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
604,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
604,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
605,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
605,2,Drug dispensed to wrong patient,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
606,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
606,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
607,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
608,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
609,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
609,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
610,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
610,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
611,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
611,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
612,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
612,2,Headache,Headaches NEC,Headaches,Nerv,N
613,1,Post procedural hypotension,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
614,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
614,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
614,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
614,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
614,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
614,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
614,7,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
615,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
616,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
617,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
618,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
618,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
619,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
619,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
619,3,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
620,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
620,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
621,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
621,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
621,3,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
622,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
623,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
623,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
624,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
624,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
625,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
625,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
626,1,Catheter site erythema,Implant and catheter site reactions,Administration site reactions,Genrl,N
626,2,Catheter site vesicles,Implant and catheter site reactions,Administration site reactions,Genrl,N
627,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
628,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
628,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
628,3,Epileptic encephalopathy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
628,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
629,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
629,2,Corneal reflex decreased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
629,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
629,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
629,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
630,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
630,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
631,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
632,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
632,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
632,3,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
632,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
632,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
632,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
633,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
633,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
633,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
633,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
633,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
634,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
635,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
635,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
635,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
635,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
636,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
636,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
636,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
636,4,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
636,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
637,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
638,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
639,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
639,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
639,3,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
640,1,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
640,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
641,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
641,2,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
641,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
641,4,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
641,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
642,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
642,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
642,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
643,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
643,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
644,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
644,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
644,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
645,1,Hypoventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
645,2,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
645,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
646,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
647,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
647,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
647,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
647,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
647,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
647,6,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
647,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
648,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
649,1,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
649,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
649,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
649,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
650,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
650,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
650,3,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
651,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
652,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
653,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
653,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
653,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
653,4,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
654,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
654,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
654,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
654,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
654,5,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
654,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
654,7,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
655,1,Hypoventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
655,2,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
655,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
655,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
656,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
657,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
658,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
659,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
659,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
659,3,Azotaemia,Renal failure complications,Renal disorders (excl nephropathies),Renal,N
659,4,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
659,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
659,6,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
660,1,Hyporesponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
660,2,Snoring,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
661,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
661,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
661,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
662,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
662,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
662,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
662,4,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
663,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
664,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
664,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
665,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
665,2,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
666,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
667,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
668,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
668,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
668,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
668,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
668,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
668,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
669,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
669,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
669,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
670,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
671,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
671,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
672,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
673,1,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
674,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
674,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
674,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
675,1,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
675,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
675,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
676,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
677,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
677,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
677,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
677,4,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
677,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
677,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
678,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
678,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
678,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
679,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
680,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
680,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
681,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
681,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
682,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
683,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
684,1,Brain hypoxia,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,Y
684,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
685,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
686,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
686,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
686,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
687,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
688,1,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
688,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
688,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
689,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
689,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
690,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
690,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
691,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
691,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
692,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
692,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
692,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
693,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
693,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
693,3,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
693,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
694,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
694,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
694,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
694,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
694,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
694,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
695,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
695,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
695,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
696,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
696,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
697,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
697,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
697,3,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
697,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
698,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
699,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
700,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
700,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
701,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
701,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
701,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
701,4,Euthyroid sick syndrome,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
701,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
701,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
701,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
701,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
701,9,Intensive care unit delirium,Deliria,Deliria (incl confusion),Psych,N
701,10,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
701,11,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
701,12,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
701,13,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
701,14,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
701,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
701,16,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
701,17,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
702,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
702,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
702,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
702,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
702,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
702,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
702,7,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
702,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
702,9,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
702,10,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
702,11,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
702,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
702,13,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
703,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
703,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
703,3,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
703,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
703,5,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
703,6,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
703,7,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
703,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
703,9,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
703,10,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
703,11,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
703,12,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
703,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
703,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
703,15,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
703,16,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
704,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
704,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
705,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
705,2,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
705,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
705,4,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
706,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
706,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
706,3,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
706,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
707,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
707,2,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
707,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
708,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
709,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
709,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
710,1,Auditory disorder,Hearing disorders NEC,Hearing disorders,Ear,N
710,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
710,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
710,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
710,5,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
710,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
711,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
711,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
711,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
711,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
711,5,Procedural vomiting,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
712,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
713,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
713,2,Victim of chemical submission,Crime victims,Legal issues,SocCi,N
713,3,Victim of sexual abuse,Crime victims,Legal issues,SocCi,N
714,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
714,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
715,1,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
715,2,Irregular breathing,Breathing abnormalities,Respiratory disorders NEC,Resp,N
716,1,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
716,2,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
716,3,Irregular breathing,Breathing abnormalities,Respiratory disorders NEC,Resp,N
716,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
716,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
717,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
718,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
719,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
719,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
719,3,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
719,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
719,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
719,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
719,7,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
719,8,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
719,9,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
719,10,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
719,11,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
719,12,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
719,13,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
719,14,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
719,15,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
719,16,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
719,17,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
719,18,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
719,19,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
720,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
720,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
720,3,Endotracheal intubation complication,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
720,4,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
721,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
721,2,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
721,3,Post-traumatic stress disorder,Stress disorders,Anxiety disorders and symptoms,Psych,N
721,4,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
722,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
723,1,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
723,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
723,3,Infective pulmonary exacerbation of cystic fibrosis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
723,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
724,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
724,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
724,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
724,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
724,5,Haematuria traumatic,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
724,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
724,7,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
724,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
724,9,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
724,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
724,11,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
724,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
725,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
725,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
725,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
725,4,Euthyroid sick syndrome,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
725,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
725,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
725,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
725,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
725,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
725,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
725,11,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
725,12,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
726,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
726,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
726,3,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
726,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
726,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
727,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
727,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
727,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
727,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
727,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
727,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
727,7,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
727,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
727,9,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
727,10,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
727,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
727,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
728,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
728,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
728,3,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
728,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
728,5,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
728,6,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
728,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
728,8,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
728,9,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
728,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
729,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
729,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
729,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
729,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
729,5,Haematuria traumatic,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
729,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
729,7,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
729,8,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
729,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
729,10,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
729,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
729,12,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
729,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
730,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
730,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
730,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
730,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
730,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
731,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
731,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
731,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
732,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
732,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
732,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
733,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
733,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
733,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
734,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
735,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
735,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
735,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
735,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
735,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
736,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
737,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
738,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
738,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
739,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
739,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
740,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
740,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
740,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
741,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
741,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
742,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
742,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
742,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
743,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
743,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
743,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
743,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
744,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
744,2,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
744,3,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
745,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
745,2,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
745,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
745,4,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
746,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
746,2,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
747,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
747,2,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
748,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
748,2,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
748,3,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
749,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
749,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
749,3,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
750,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
750,2,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
750,3,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
751,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
751,2,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
751,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
751,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
752,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
752,2,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
753,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
753,2,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
753,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
753,4,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
754,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
754,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
754,3,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
754,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
754,5,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
754,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
754,7,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
754,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
754,9,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
754,10,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
754,11,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
754,12,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
754,13,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
754,14,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
754,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
754,16,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
754,17,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
755,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
755,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
755,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
755,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
755,5,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
755,6,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
755,7,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
755,8,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
755,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
756,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
756,2,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
756,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
756,4,Haematuria traumatic,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
756,5,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
756,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
756,7,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
756,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
756,9,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
756,10,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
756,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
756,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
756,13,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
756,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
757,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
757,2,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
757,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
757,4,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
758,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
758,2,Euthyroid sick syndrome,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
758,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
758,4,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
758,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
758,6,Intensive care unit delirium,Deliria,Deliria (incl confusion),Psych,N
758,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
758,8,Neuromyopathy,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
758,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
759,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
759,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
759,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
759,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
759,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
759,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
759,7,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
759,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
759,9,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
759,10,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
759,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
760,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
760,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
760,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
760,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
761,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
761,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
761,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
762,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
763,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
763,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
764,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
765,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
766,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
767,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
767,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
768,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
768,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
768,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
768,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
768,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
769,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
769,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
769,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
769,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
770,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
771,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
771,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
771,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
772,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
772,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
773,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
773,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
773,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
773,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
773,5,Hepatic ischaemia,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
773,6,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
773,7,Hepatorenal syndrome,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
773,8,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
773,9,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
773,10,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
773,11,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
773,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
773,13,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
774,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
775,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
775,2,Headache,Headaches NEC,Headaches,Nerv,N
775,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
776,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
776,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
776,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
776,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
776,5,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
776,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
776,7,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
776,8,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
776,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
776,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
776,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
776,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
776,13,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
777,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
777,2,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
777,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
777,4,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
777,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
777,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
778,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
778,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
779,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
779,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
779,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
779,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
780,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
781,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
781,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
781,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
781,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
782,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
782,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
783,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
783,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
783,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
783,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
784,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
785,1,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
786,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
786,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
786,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
786,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
786,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
786,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
786,7,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
786,8,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
786,9,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
786,10,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
787,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
787,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
787,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
787,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
787,5,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
787,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
787,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
788,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
788,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
788,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
788,4,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
788,5,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
788,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
788,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
789,1,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
789,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
790,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
791,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
791,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
792,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
792,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
792,3,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
792,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
792,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
792,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
792,7,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
792,8,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
792,9,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
792,10,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
792,11,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
792,12,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
792,13,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
792,14,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
792,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
793,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
793,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
794,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
794,2,Hereditary angioedema with C1 esterase inhibitor deficiency,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
794,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
794,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
795,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
796,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
796,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
796,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
796,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
796,5,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
796,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
796,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
797,1,Retrograde amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
798,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
798,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
799,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
800,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
800,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
800,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
801,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
802,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
803,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
803,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
804,1,Abdominal compartment syndrome,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
804,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
804,3,Acute lung injury,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
804,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
804,5,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
804,6,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
804,7,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
804,8,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
804,9,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
804,10,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
804,11,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
804,12,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
804,13,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
804,14,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
804,15,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
804,16,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
804,17,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
804,18,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
804,19,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
804,20,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
804,21,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
804,22,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
804,23,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
804,24,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
804,25,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
804,26,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
804,27,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
804,28,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
804,29,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
804,30,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
804,31,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
804,32,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
805,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
806,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
807,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
808,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
809,1,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
809,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
810,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
810,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
810,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
810,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
811,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
811,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
812,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
812,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
813,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
814,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
814,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
815,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
815,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
816,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
817,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
818,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
818,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
818,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
819,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
820,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
820,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
821,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
821,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
821,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
822,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
822,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
823,1,Microcytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
824,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
824,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
824,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
825,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
825,2,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
826,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
826,2,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
826,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
827,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
828,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
828,2,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
828,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
829,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
829,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
829,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
830,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
830,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
831,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
831,2,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
832,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
832,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
832,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
833,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
833,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
834,1,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
834,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
835,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
835,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
835,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
835,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
836,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
836,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
837,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
837,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
837,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
838,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
839,1,Change in seizure presentation,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
839,2,Epilepsy with myoclonic-atonic seizures,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
840,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
840,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
841,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
842,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
843,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
844,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
844,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
844,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
845,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
845,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
845,3,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
845,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
845,5,Delirium,Deliria,Deliria (incl confusion),Psych,N
845,6,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
845,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
846,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
846,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
846,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
846,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
846,5,Hepatic ischaemia,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
846,6,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
846,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
847,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
848,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
849,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
850,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
851,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
851,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
852,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
853,1,Athetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
854,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
854,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
854,3,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
854,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
855,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
856,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
857,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
857,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
858,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
858,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
858,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
858,4,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
858,5,Preterm premature rupture of membranes,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
859,1,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
859,2,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
859,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
859,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
860,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
860,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
861,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
861,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
861,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
862,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
862,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
863,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
863,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
863,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
864,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
865,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
865,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
865,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
865,4,New onset refractory status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
865,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
866,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
866,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
867,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
867,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
867,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
867,4,Preterm premature rupture of membranes,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
867,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
868,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
868,2,Foetal dystocia,Foetal position and presentation abnormalities,Foetal complications,Preg,N
868,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
868,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
869,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
869,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
870,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
870,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
870,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
871,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
871,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
871,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
871,4,Preterm premature rupture of membranes,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
872,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
873,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
874,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
875,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
875,2,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
875,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
875,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
876,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
876,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
876,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
876,4,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
877,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
877,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
877,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
878,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
879,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
879,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
879,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
880,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
880,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
880,3,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
880,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
880,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
880,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
881,1,Neurogenic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
882,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
883,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
883,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
884,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
885,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
885,2,Headache,Headaches NEC,Headaches,Nerv,N
885,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
886,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
886,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
886,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
887,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
888,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
888,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
889,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
890,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
890,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
890,3,Tonic clonic movements,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
891,1,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
891,2,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
892,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
892,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
893,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
894,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
894,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
894,3,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
894,4,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
894,5,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
894,6,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
894,7,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
894,8,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
894,9,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
894,10,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
894,11,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
894,12,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
894,13,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
894,14,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
894,15,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
894,16,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
894,17,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
894,18,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
895,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
895,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
896,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
896,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
897,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
898,1,Injection related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
898,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
898,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
899,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
900,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
900,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
901,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
901,2,Foetal heart rate abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
901,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
902,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
902,2,Foetal heart rate abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
902,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
903,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
903,2,Cardiac dysfunction,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
903,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
903,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
903,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
903,6,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
903,7,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
904,1,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
905,1,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
